文献速递临床试验与 GCP

手动针刺预防无先兆偏头痛:多中心、随机、单盲试验的研究方案

Manual acupuncture as prophylaxis for migraine without aura: study protocol for a multi-center, randomized, single-blinded trial.
PubMed 文献 · Trials · 2022-07-19

本研究为单盲、随机、对照、前瞻性、多中心、两平行治疗组试验,计划纳入198例无先兆偏头痛患者,按1:1随机分为手动针刺组与安慰针刺组(真穴位非穿透针刺),每周治疗3次、连续4周,随后随访12周,旨在评估手动针刺预防无先兆偏头痛的疗效与安全性。

要点

  • 试验采用真穴位非穿透针刺作为安慰对照,以评估手动针刺预防无先兆偏头痛的疗效与安全性。
  • 计划纳入198例无先兆偏头痛患者,按1:1随机分为手动针刺组与安慰针刺组。
  • 治疗为每周3次、连续4周,随后随访12周。

核心结论

  • 本试验旨在评估手动针刺预防无先兆偏头痛的疗效与安全性。
  • 安慰对照采用真穴位非穿透针刺,确定合适的对照方法对保证随机对照试验的方法学质量至关重要。

研究设计与样本

  • 单盲、随机、对照、前瞻性、多中心试验,两平行治疗组。
  • 计划纳入198例符合条件的无先兆偏头痛患者,按1:1分配比例随机分为两组。
  • 干预组接受手动针刺,对照组接受安慰针刺(非穿透针刺)。
  • 患者每周接受3次针刺治疗,连续4周,随后随访12周。

关键数值与推荐

  • 干预组接受手动针刺,对照组接受安慰针刺(非穿透针刺)。
  • 两组均每周治疗3次、连续4周,随后随访12周。
  • 计划样本量为198例无先兆偏头痛患者,按1:1随机分配。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Migraine is a highly prevalent neurological disorder. It is the third most prevalent disorder and the seventh highest cause of disability worldwide. Acupuncture may be a viable prophylactic treatment option for frequent or uncontrolled migraine. Clinical studies comparing acupuncture and placebo acupuncture have not reached a consistent conclusion in confirming whether acupuncture is effective in migraine prophylaxis. The effect of acupuncture mainly depends on acupoints and needles operation. We found that the design of the placebo acupuncture in previous studies included shallow needling at sham acupoints, non-penetrating needling at sham acupoints, and needling at inactive acupuncture points to achieve the inert effect of control group, but the non-penetrating needling at true acupoints was ignored. This randomized controlled trial aims to use true acupoints for non-penetrating acupuncture as control to evaluate the efficacy of manual acupuncture for the prophylaxis of migraine without aura (MWoA). METHODS/DESIGN: This is a single-blinded, randomized, controlled, prospective, multi-center trial with two parallel treatment groups. A total of 198 eligible patients with MWoA will be randomly divided into two groups (1:1 allocation ratio). The intervention group will receive manual acupuncture and the control group will receive placebo acupuncture (non-penetrating). Patients will receive three acupuncture treatment sessions per week for 4 consecutive weeks. All patients will then receive a 12-week follow-up. DISCUSSION: In this study, we are evaluating the efficacy and safety of manual acupuncture in the prophylaxis of MWoA. The placebo control is using non-penetrating needling verum acupoints. It is essential to determine an appropriate control method to ensure the methodological quality of a randomized controlled trial. TRIAL REGISTRATION: The trial has been registered in the Chinese Clinical Trial Registry (approval no. ChiCTR2000032308 ) in April 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Chen J, Zhou S, Sun M, et al. Manual acupuncture as prophylaxis for migraine without aura: study protocol for a multi-center, randomized, single-blinded trial. Trials. 2022. PMID: 35854329. doi:10.1186/s13063-022-06510-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。